Ventyx Biosciences (VTYX)
(Delayed Data from NSDQ)
$2.53 USD
-0.05 (-1.94%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.52 -0.01 (-0.40%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Ventyx Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VTYX 2.53 -0.05(-1.94%)
Will VTYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VTYX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VTYX
Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock?
VTYX Stock Rises on Strategic Equity Investment Deal With SNY
VTYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VTYX
Commit To Buy Ventyx Biosciences At $2.50, Earn 56.9% Annualized Using Options
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Ventyx Biosciences (VTYX)
Oppenheimer Reaffirms Their Buy Rating on Ventyx Biosciences (VTYX)
Hold Rating for Ventyx Biosciences Amid Promising Early Data and Strategic Uncertainties
Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments